Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Oportun Financial (OPRT) Research & Development (2018 - 2026)

Oportun Financial filings provide 8 years of Research & Development readings, the most recent being $16.1 million for Q4 2025.

  • On a quarterly basis, Research & Development fell 6.78% to $16.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $70.6 million, a 5.41% increase, with the full-year FY2025 number at $70.6 million, up 5.41% from a year prior.
  • Research & Development hit $16.1 million in Q4 2025 for Oportun Financial, down from $16.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $37.1 million in Q4 2021 to a low of $16.0 million in Q1 2024.
  • Median Research & Development over the past 5 years was $19.2 million (2023), compared with a mean of $22.0 million.
  • Biggest five-year swings in Research & Development: soared 55.69% in 2021 and later crashed 44.47% in 2023.
  • Oportun Financial's Research & Development stood at $37.1 million in 2021, then crashed by 42.53% to $21.3 million in 2022, then decreased by 15.41% to $18.1 million in 2023, then fell by 4.13% to $17.3 million in 2024, then fell by 6.78% to $16.1 million in 2025.
  • The last three reported values for Research & Development were $16.1 million (Q4 2025), $16.5 million (Q3 2025), and $18.1 million (Q2 2025) per Business Quant data.